Cancer Institute A national cancer institute
designated cancer center
Email this profile
Portrait View Larger

Wen-Kai Weng, MD, PhD

Academic Appointments

  • Assistant Professor of Medicine (Blood and Marrow Transplantation) and, by courtesy, of Dermatology at the Stanford University Medical Center

Key Documents

Contact Information

  • Clinical Offices
    Blood and Marrow Transplant Clinic 875 Blake Wilbur Dr Clinic F MC 5826 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 498-6919
  • Academic Offices
    Personal Information
    Email Tel (650) 723-7689
    Alternate Contact
    Janice Smith Administrative Associate Tel Work 650-724-4155
    Not for medical emergencies or patient use


Clinical Focus

  • Cancer> Blood and Marrow Transplant
  • Cancer> Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Medical Oncology
  • Myeloma

Academic Appointments

Administrative Appointments

  • Scientific Advisory Board, Lymphoma Research Foundation (2011 - present)

Honors and Awards

  • Translational Research Grant, Stanford Cancer Institute (2014-2015)
  • Division Teaching Award, BMT, Stanford University (2012)
  • Developmental Research Award, Stanford Cancer Institute (2012-2013)
  • ITI Seed Grant Award, Institute for Immunity, Transplantation and Infection, Stanford University (2011-2012)
  • Division Teaching Award, BMT, Stanford University (2010)
  • Developmental Research Award, Stanford University Cancer Center (2009-2010)
View All 12honors and awards of Wen-Kai Weng

Professional Education

Medical Education: Chungshan Medical College (1988)
University of Minnesota MN (1996)
Internship: University of Texas Medical School TX (1997)
Residency: University of Texas Medical School TX (1999)
Fellowship: Stanford University School of Medicine CA (2002)
Board Certification: Internal Medicine, American Board of Internal Medicine (2007)
View All 7

Research & Scholarship

Current Research and Scholarly Interests

My clinical focus is non-Hodgkin's lymphoma (NHL) and am currently conducting clinical trials with novel therapies on these patients. My basic research interest is immunotherapy for lymphoma, with two components: tumor vaccines and allogeneic transplant. For the tumor vaccine, I am working with my colleagues in Oncology to conduct a clinical trial using a CpG-activated tumor vaccine in mantel cell NHL patients who undergo autologous transplantation. The goal is to sensitize the autologous T cells to recognize the malignant lymphoma cells and to expand these tumor-specific T cells immediate after autologous transplant.

Second, I am conducting a study using a novel non-myeloablative preparative regimen prior to allogeneic transplant in patients with mycosis fungoides/Sezary syndrome, a cutaneous T cell NHL. While these patients exhibit little sensitivity to traditional chemotherapy, graft-versus-lymphoma effect provided by allogeneic transplant seems to have an excellent disease control effect. I also use high throughput sequencing technology to assess the minimal residual disease and the immune reconstitution after allogeneic transplant.




Graduate and Fellowship Program Affiliations



Publication tag cloud

Publication Topics

View All 27

Stanford Medicine Resources:

Footer Links: